BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5289430)

  • 1. Studies with a 2,4-diamino-5-chloro-quinazoline antifolate: in vitro and invivo correlates in normal and lymphosarcoma dogs.
    Fölsch E; Abboud G; Gralla E; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():501-13. PubMed ID: 5289430
    [No Abstract]   [Full Text] [Related]  

  • 2. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro.
    Kamen BA; Eibl B; Cashmore A; Bertino J
    Biochem Pharmacol; 1984 May; 33(10):1697-9. PubMed ID: 6233981
    [No Abstract]   [Full Text] [Related]  

  • 3. Quinazoline antifolates as inhibitors of dihydrofolate reductase from human leukemia cells.
    Johns DG; Capizzi RL; Nahas A; Cashmore AR; Bertino JR
    Biochem Pharmacol; 1970 Apr; 19(4):1528-33. PubMed ID: 5284463
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicologic studies of the 2,4-diamino-quinazoline antifolate, methasquin (NSC-122870).
    Philips FS; Sternberg SS; Sodergren JE; Vidal P
    Cancer Chemother Rep; 1971 Feb; 55(1):35-42. PubMed ID: 5001089
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of chemotherapeutic agents with methotrexate and 5-fluorouracil and its effect on de novo DNA synthesis.
    Bruckner HW; Schreiber C; Waxman S
    Cancer Res; 1975 Mar; 35(3):801-6. PubMed ID: 1116135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Threshold methotrexate concentration for in vivo inhibition of DNA synthesis in normal and tumorous target tissues.
    Chabner BA; Young RC
    J Clin Invest; 1973 Aug; 52(8):1804-11. PubMed ID: 4719662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the poor correlation between the inhibition by methotrexate of dihydrofolate reductase and of deoxynucleoside incorporation into DNA.
    Roberts D; Wodinsky I
    Cancer Res; 1968 Oct; 28(10):1955-62. PubMed ID: 5696929
    [No Abstract]   [Full Text] [Related]  

  • 8. Quinazoline antifolates: biologic activities.
    Hutchison DJ
    Cancer Chemother Rep; 1968 Dec; 52(7):697-705. PubMed ID: 5754669
    [No Abstract]   [Full Text] [Related]  

  • 9. Paradoxical effect of BW 301U, a lipophilic antifolate, on methotrexate-inhibitable deoxyuridine incorporation by human hematopoietic cells.
    Iland HJ; Laszlo J; Sedwick WD
    Cancer Res; 1985 Aug; 45(8):3962-8. PubMed ID: 3860291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
    Waxman S; Herbert V
    N Engl J Med; 1969 Jun; 280(24):1316-9. PubMed ID: 5771778
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of trimethoprim on folate-dependent DNA synthesis in human bone marrow.
    Sive J; Green R; Metz J
    J Clin Pathol; 1972 Mar; 25(3):194-7. PubMed ID: 5018713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The basis for the disparate sensitivity of L1210 leukemia and Walker 256 carcinoma to a new triazine folate antagonist.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1973 Nov; 33(11):2972-6. PubMed ID: 4748449
    [No Abstract]   [Full Text] [Related]  

  • 13. Uptake of methotrexate, aminopterin, and methasquin and inhibition of dihydrofolate reductase and of DNA synthesis in mouse small intestine.
    Philips FS; Sirotnak FM; Sodergren JE; Hutchison DJ
    Cancer Res; 1973 Jan; 33(1):153-8. PubMed ID: 4682318
    [No Abstract]   [Full Text] [Related]  

  • 14. The intracellular concentration dependence of antifolate inhibition of DNA synthesis in L1210 leukemia cells.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1974 Dec; 34(12):332-40. PubMed ID: 4429954
    [No Abstract]   [Full Text] [Related]  

  • 15. New approaches to chemotherapy.
    Hutchison DJ
    Ann N Y Acad Sci; 1971 Nov; 186():496-500. PubMed ID: 5002440
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of amethopterin treatment on thymidylate synthesis in human leucocytes and bone marrow cells.
    Wilmanns W
    Ann N Y Acad Sci; 1971 Nov; 186():365-71. PubMed ID: 4943808
    [No Abstract]   [Full Text] [Related]  

  • 17. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo.
    Bertino JR; Sawicki WL; Moroson BA; Cashmore AR; Elslager EF
    Biochem Pharmacol; 1979 Jun; 28(12):1983-7. PubMed ID: 454469
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-folate toxicity and its reversal.
    Harrap KR
    Biochem Soc Trans; 1976; 4(5):856-9. PubMed ID: 793905
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of DNA synthesis in normal and malignant human cells by triazinate (Baker's antifol) and methotrexate.
    Skeel RT; Sawicki WL; Cashmore AR; Bertino JR
    Cancer Res; 1976 Oct; 36(10):3659-64. PubMed ID: 953990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of thymine nucleotides synthesized via the 'de novo' mechanism in normal, megaloblastic and methotrexate-treated human cells and in a lymphoblastoid cell line.
    Taheri MR; Wickremasinghe RG; Hoffbrand AV
    Biochem J; 1981 Apr; 196(1):225-35. PubMed ID: 6946768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.